• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阴道痉挛的心理生物学相关性:探索性分析。

Psychobiological Correlates of Vaginismus: An Exploratory Analysis.

机构信息

Gynecological Endocrinology Research Unit, Department of Experimental, Clinical and Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.

Gynecology and Obstetrics Unit, Department of Experimental, Clinical and Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.

出版信息

J Sex Med. 2017 Nov;14(11):1392-1402. doi: 10.1016/j.jsxm.2017.09.015.

DOI:10.1016/j.jsxm.2017.09.015
PMID:29110807
Abstract

BACKGROUND

Evidence concerning the determinants of vaginismus (V), in particular medical conditions, is inconclusive.

AIM

To investigate, in a cohort of subjects consulting for female sexual dysfunction, whether there is a difference in medical and psychosocial parameters between women with V and women with other sexual complaints.

METHODS

A series of 255 women attending our clinic for female sexual dysfunction was consecutively recruited. V was diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision criteria. Lifelong and acquired V cases were included.

OUTCOMES

Patients underwent a structured interview and physical, gynecologic, laboratory, and clitoral ultrasound examinations; they completed the Female Sexual Function Index (FSFI), the Middlesex Hospital Questionnaire, the Female Sexual Distress Scale-Revised (FSDS), and the Body Uneasiness Test.

RESULTS

V was diagnosed in 20 patients (7.8%). Women with V were significantly younger than the rest of the sample (P < .05). No differences were found for traditional risk factors such as a history of sexual abuse, relational parameters, or gynecologic diseases or for newly investigated parameters (ie, neurologic, hormonal, and metabolic alterations). Women with V showed significantly higher histrionic-hysterical symptoms and traits (as detected by MHQ-H score; P < .05) compared with subjects with other sexual complaints. When the scores of all MHQ subscales were simultaneously introduced in a logistic model, the association between V and MHQ-H score was confirmed (P = .013). Women with V also showed higher FSFI pain and FSDS total scores, even after adjusting for age (P < .05). In an age-adjusted model, FSDS total score increased as a function of the years of duration of V (P = .032) but not as a function of its severity. All observations were confirmed in a case-control study (ratio = 1:3).

CLINICAL IMPLICATIONS

Our data demonstrate that some novel contributors of V should be investigated, namely histrionic-hysterical traits. This psychological comorbidity could offer valuable insights for intervention and managing complications.

STRENGTHS AND LIMITATIONS

This is the first study to assess the role of many metabolic and hormonal parameters as potential determinants of V. The main limitation is its exploratory and cross-sectional nature; our data need to be confirmed in larger, more systematic analyses.

CONCLUSION

V was associated with histrionic-hysterical traits, FSFI pain domain, and sex-related distress. A history of abuse, relational parameters, gynecologic diseases, and hormonal and metabolic alterations do not seem to play a role in the development of V. Maseroli E, Scavello I, Cipriani S, et al. Psychobiological Correlates of Vaginismus: An Exploratory Analysis. J Sex Med 2017;14:1392-1402.

摘要

背景

关于阴道痉挛(V)决定因素的证据,特别是医学状况的证据,尚无定论。

目的

在因女性性功能障碍就诊的受试者队列中,调查 V 与其他性抱怨的女性之间在医学和社会心理参数方面是否存在差异。

方法

连续招募了 255 名来我们诊所就诊的女性性功能障碍患者。根据《精神障碍诊断与统计手册》第四版修订版标准诊断 V。包括终身和获得性 V 病例。

结果

患者接受了结构化访谈以及身体、妇科、实验室和阴蒂超声检查;他们完成了女性性功能指数(FSFI)、米德尔塞克斯医院问卷、女性性功能困扰量表修订版(FSDS)和身体不适测试。

结论

V 被诊断为 20 名患者(7.8%)。V 组的女性明显比其他组的女性年轻(P<.05)。在性虐待史、关系参数或妇科疾病等传统危险因素或新调查的参数(即神经、激素和代谢改变)方面,没有发现差异。与其他性抱怨的受试者相比,V 组的患者表现出明显更高的戏剧-癔症症状和特征(通过 MHQ-H 评分检测;P<.05)。当所有 MHQ 子量表的分数同时引入逻辑模型时,V 与 MHQ-H 评分之间的关联得到确认(P=.013)。即使调整年龄因素,V 组的 FSFI 疼痛和 FSDS 总分也较高(P<.05)。在年龄调整模型中,V 的持续时间(P=.032)而不是严重程度(P=.032)会导致 FSDS 总分增加。在病例对照研究(比例= 1:3)中证实了所有观察结果。

意义

我们的数据表明,应该研究一些阴道痉挛的新发病因,即戏剧-癔症特征。这种心理共病可以为干预和管理并发症提供有价值的见解。

局限性

这是第一项评估许多代谢和激素参数作为阴道痉挛潜在决定因素的研究。主要的限制是其探索性和横断面性质;我们的数据需要在更大、更系统的分析中得到证实。

E. Maseroli 等人,《阴道痉挛的心理生物学相关性:一项探索性分析》,《性医学杂志》2017 年;14:1392-1402。

相似文献

1
Psychobiological Correlates of Vaginismus: An Exploratory Analysis.阴道痉挛的心理生物学相关性:探索性分析。
J Sex Med. 2017 Nov;14(11):1392-1402. doi: 10.1016/j.jsxm.2017.09.015.
2
Psychosexual Correlates of Unwanted Sexual Experiences in Women Consulting for Female Sexual Dysfunction According to Their Timing Across the Life Span.根据女性在整个生命周期中出现女性性功能障碍的时间,探讨女性咨询者的非意愿性性经历的心理性相关因素。
J Sex Med. 2018 Dec;15(12):1739-1751. doi: 10.1016/j.jsxm.2018.10.004. Epub 2018 Nov 13.
3
Physical Activity and Female Sexual Dysfunction: A Lot Helps, But Not Too Much.身体活动与女性性功能障碍:多有帮助,但不过量。
J Sex Med. 2021 Jul;18(7):1217-1229. doi: 10.1016/j.jsxm.2021.04.004. Epub 2021 Jun 5.
4
Vaginismus and accompanying sexual dysfunctions in a Turkish clinical sample.土耳其临床样本中的阴道痉挛及伴随的性功能障碍
J Sex Med. 2009 Jan;6(1):184-92. doi: 10.1111/j.1743-6109.2008.01048.x.
5
Prevalence of and Risk Factors for Genito-Pelvic Pain/Penetration Disorder: A Population-Based Study of Iranian Women.生殖器-盆腔疼痛/插入障碍的流行情况和危险因素:伊朗女性的一项基于人群的研究。
J Sex Med. 2019 Jul;16(7):1068-1077. doi: 10.1016/j.jsxm.2019.04.019. Epub 2019 May 31.
6
Attentional Bias for Pain and Sex, and Automatic Appraisals of Sexual Penetration: Differential Patterns in Dyspareunia vs Vaginismus?对疼痛和性的注意偏向以及对性插入的自动评估:性交困难与阴道痉挛的差异模式?
J Sex Med. 2016 Aug;13(8):1255-62. doi: 10.1016/j.jsxm.2016.05.008. Epub 2016 Jun 18.
7
Factors Associated With Specific Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Sexual Dysfunctions in Breast Cancer Survivors: A Study of Patients and Their Partners.与乳腺癌幸存者特定的《精神疾病诊断与统计手册》第四版性障碍相关的因素:患者及其伴侣的研究。
J Sex Med. 2017 Oct;14(10):1248-1259. doi: 10.1016/j.jsxm.2017.08.004. Epub 2017 Sep 8.
8
Predictors of task-persistent and fear-avoiding behaviors in women with sexual pain disorders.患有性疼痛障碍的女性中任务坚持行为和恐惧回避行为的预测因素。
J Sex Med. 2014 Dec;11(12):3051-63. doi: 10.1111/jsm.12697. Epub 2014 Sep 18.
9
A comparative study of sexual function, behavior, and cognitions of women with lifelong vaginismus.先天性阴道痉挛女性性功能、性行为及认知的比较研究
Arch Sex Behav. 2013 Nov;42(8):1605-14. doi: 10.1007/s10508-013-0111-3. Epub 2013 Jun 4.
10
Vaginismus and its correlates in an Iranian clinical sample.伊朗临床样本中的阴道痉挛及其相关因素。
Int J Impot Res. 2014 Nov-Dec;26(6):230-4. doi: 10.1038/ijir.2014.16. Epub 2014 May 15.

引用本文的文献

1
Knowledge and Prevalence of Vaginismus Among Women in Najran, Saudi Arabia.沙特阿拉伯奈季兰地区女性阴道痉挛的知晓率与患病率
Cureus. 2023 Nov 10;15(11):e48602. doi: 10.7759/cureus.48602. eCollection 2023 Nov.
2
Component of sexual health services for vaginismus management: A qualitative study.阴道痉挛管理的性健康服务内容:一项定性研究。
PLoS One. 2023 Aug 9;18(8):e0283732. doi: 10.1371/journal.pone.0283732. eCollection 2023.
3
Alexithymia and Parental Bonding in Women with Genitopelvic Pain/Penetration Disorder.患有盆腔疼痛/性交障碍的女性的述情障碍与父母养育方式
Neuropsychiatr Dis Treat. 2022 Dec 23;18:3023-3033. doi: 10.2147/NDT.S389008. eCollection 2022.
4
Bio-psychosocial factor of vaginismus in Iranian women.伊朗女性阴道痉挛的生物-心理-社会因素。
Reprod Health. 2021 Oct 18;18(1):210. doi: 10.1186/s12978-021-01260-2.
5
The role of personal factors in quality of life among Iranian women with vaginismus: a path analysis.个人因素在伊朗阴道痉挛女性生活质量中的作用:路径分析。
Health Qual Life Outcomes. 2021 Jun 15;19(1):166. doi: 10.1186/s12955-021-01799-5.
6
Sexual Health Implications of COVID-19 Pandemic.COVID-19 大流行对性健康的影响。
Sex Med Rev. 2021 Jan;9(1):3-14. doi: 10.1016/j.sxmr.2020.10.004. Epub 2020 Nov 5.
7
Female Veterans' Experiences With VHA Treatment for Military Sexual Trauma.女性退伍军人接受退伍军人健康管理局(VHA)治疗军事性创伤的经历。
Fed Pract. 2019 Jan;36(1):41-47.